Is Vivek Ramaswamy A BioTech Ponzi Schemer & Deep State Asset?
JAN 15, 2024
Biotech entrepreneur and Republican presidential candidate Vivek Ramaswamy has made all of the right promises to his conservative base. With a seemingly solid grasp of the Constitution, a deft ability to articulate current nationalistic grievances, and as author of the book “Woke, Inc.: Inside Corporate America’s Social Justice Scam,” Ramaswamy represents the future of America’s right-wing political movement.
Admitting that the last presidential election was clearly stolen, that J6 was a government entrapment operation as run by FBI assets on the ground, that the Democrats are Marxists that want to destroy America via open borders, welfare, and identity politics must surely sound like the most mellifluous music to the average conservative voter’s ears.
End affirmative action … close down the Education Department, limit the power of the Federal Reserve, send U.S. armed forces to the Mexican border.
As a staunch critic of the environmental, social and corporate governance (E.S.G.) grift, he has been slamming firms like BlackRock, Vanguard, and State Street. He considers these corporate entities and their “socially conscious investing” the single greatest threat to America’s existence. He is not wrong, given how this pernicious partnership between the private sector and an illegitimate Federal government serves to, “do through the back door what our government couldn’t directly get done through the front door.”
After working in Silicon Valley and Wall Street, Ramaswamy founded biotech company Roivant Sciences in 2014. The following year he raised $360 million for the Roivant subsidiary Axovant Sciences in order to market an Alzheimer's drug that had previously failed four separate clinical trials. He then raised another $315 million in the IPO. Shortly thereafter, the company's market value reached almost $3 billion. Two years later, their drug failed its fifth clinical trial. The company cratered, losing over 70% of its value in a single day. Ramaswamy’s investors would be the quintessential bag-holders, while he made out with windfall profits at their expense.
And yet in 2017, Roivant partnered with the private equity arm of the CCP’s CITIC Group to form yet another fraudulent company called Sinovant. Shortly thereafter, SoftBank invested $1.1 billion in Roivant. In 2019, Roivant sold its stake in five subsidiaries, and Ramaswamy pocketed $175 million from the deal.
Roivant has never produced a single viable product, and has never turned a profit; in other words, Roivant was always nothing more than a Ponzi Scheme, and an egregious one at that.
Despite never having created anything in his life other than a series of companies engaged in various blatant scams, Forbes recently estimated Ramaswamy's net worth to be more than $950 million.
But it gets worse, because as it turns out the very corporations such as BlackRock and Vanguard that Ramaswamy has been vehemently denouncing were doing business with him all along.
Popular podcaster Matt Kim does an excellent job of exposing Ramaswamy in this short clip:
https://www.2ndsmartestguyintheworld.com/p/is-vivek-ramaswamy-a-biotech-ponzi?utm_source=post-email-title&publication_id=400535&post_id=140692919&utm_campaign=email-post-title&isFreemail=true&r=ypwpf&utm_medium=email